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Abstract: Genomics has revolutionised the study of the biology of parasitic diseases. The first
Eukaryotic parasite to have its genome sequenced was the malaria parasite Plasmodium falciparum.
Since then, Plasmodium genomics has continued to lead the way in the study of the genome biology of
parasites, both in breadth—the number of Plasmodium species’ genomes sequenced—and in depth—
massive-scale genome re-sequencing of several key species. Here, we review some of the insights
into the biology, evolution and population genetics of Plasmodium gained from genome sequencing,
and look at potential new avenues in the future genome-scale study of its biology.
Keywords: Plasmodium; malaria; genomics; methylomics; methylation
1. Introduction
Since the genome of the malaria parasite Plasmodium falciparum was published in
2002 [1], alongside that of its mosquito vector [2] and its human host (Consortium and
International Human Genome Sequencing Consortium, 2001) [3], malaria genomics has
led the way in the study of eukaryotic pathogens. Since then, a growing number of
Plasmodium species’ genomes have been sequenced and large-scale population resequencing
studies have been carried out in P. falciparum and several other species. These efforts have
allowed the evolutionary and population genomics of malaria parasites to be studied in
unprecedented detail and provide a model for the application of genomics to the study
of other parasite species. The application of other genome-wide sequencing analyses
(e.g., transcriptomics and methylomics) broadens our knowledge of Plasmodium biology
and presents new frontiers to study. Here we consider some of these and how they can
be studied at scale. This review presents some of the key advances in the study of the
evolutionary genomics of malaria parasites made possible by the application of genomic
sequencing technologies.
2. Expanding Horizons: Sequencing Across the Genus Plasmodium
The genus Plasmodium contains a huge number of species that parasitise a wide range
of vertebrate hosts (Figure 1). For a broad view of the phylogenetic relationships among
the malaria parasites, see [4]. At the time of writing, 5-6 Plasmodium species are known
to infect humans. Four of these have been known for many years: Plasmodium falciparum
and Plasmodium vivax are the most widespread and clinically important species, with
Plasmodium malariae and Plasmodium ovale both less common and less well studied. More
recently, these have been joined by Plasmodium knowlesi, a zoonotic malaria that primarily
infects macaques, and P. ovale has been recognised as not one but two (probable) species:
P. ovale curtisi and P. ovale wallikeri [5].
Plasmodium genomes are, in some ways, rather attractive genomes to sequence: hap-
loid in the vertebrate host (and in vitro culture), not too large (around 23 Mb, encoding
around 5500 genes for P. falciparum) and with 14 well-defined chromosomes. In other
ways they present technical challenges: they are extremely AT-rich, the resulting lowered
complexity of parts of the genome increasing the challenge in sequencing and assembly.
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However, these challenges have been overcome and as a result, a large and growing num-
ber of Plasmodium species’ genomes have been fully sequenced and assembled, to varying
levels of completeness. For some reference genomes, initial sequencing and assembly
efforts using first- and second-generation sequencing technologies have subsequently been
improved using third-generation, long read sequencing technology. Additional strains
have also been independently sequenced and assembled for several species [6–9].
Genes 2021, 12, x FOR PEER REVIEW 2 of 19 
 
 
complexity of parts of the genome increasing the challenge in sequencing and assembly. 
However, these challenges have been overcome and as a result, a large and growing num-
ber of Plasmodium species’ genomes have been fully sequenced and assembled, to varying 
levels of completeness. For some reference genomes, initial sequencing and assembly ef-
forts using first- and second-generation sequencing technologies have subsequently been 
improved using third-generation, long read sequencing technology. Additional strains 
have also been independently sequenced and assembled for several species [6–9]. 
 
Figure 1. Phylogeny of malaria parasites, showing the relationships among human-infecting spe-
cies. The tree is a schematic diagram indicating topology (branch lengths are not to scale). The 
phylogenetic positions of human-infecting Plasmodium species are indicated. More detailed sub-
trees are shown for major lineages of simian malaria parasites and for the Laverania subgenus of 
ape parasites. Host species are indicated in brackets (hu = human; ma = macaque; ch = chimpan-
zee; go = gorilla). Tree topologies are after [4], and after [10] for the Laverania. 
Alongside Plasmodium falciparum [1], the other human malaria parasites P. vivax 
[6,11], P. malariae, P. ovale curtisi and P. ovale wallikeri [12–14] have been sequenced. Other 
members of the subgenus Laverania, parasites of African great apes, have been sequenced 
including the chimpanzee parasites P. reichenowi and P. adleri and gorilla parasites P. ga-
boni, P. blacklocki and P. billcollinsi [10,15]. A P. vivax-like parasite of great apes has also 
been sequenced [13]. The simian parasite of macaques and zoonotic human pathogen P. 
knowlesi has been sequenced [16,17], as well as other simian parasites including P. coatneyi 
[18] and P. cynomolgi [8,9]. Outside of the primate malarias, the genomes of rodent malaria 
parasites P. berghei, P. chabaudi chabaudi and P. yoelii yoelii, important model species for the 
study of malaria biology, have been sequenced [7,19–22]. Two avian malaria species, P. 
gallinaceum and P. relictum, have been sequenced [23]. Additional strains have also been 
independently sequenced and assembled for P. falciparum [24], P. vivax [6,11] and P. cyno-
molgi [8,9]. Together, this represents an enviably richly sequenced genus. 
Having so many species’ genomes provides a rich resource for studying evolution in 
the genus. For example, an early study of comparative structural genomics between P. 
(http://creativecommons.org/licenses
/by/4.0/). 
Figure 1. Phylogeny of malaria parasites, showing the relationships among human-infecting species.
The tree is a schematic diagram indicating topology (branch lengths are ot to scale). The phylogenetic
positions of human-infecting Plasmodium species are indicated. Mo detailed subtre s are shown for
major lin ages of simian malaria parasites d for the Laverani subgenus of ape p rasites. Host
species are indicated in brackets (hu = human; ma = macaque; ch = chimpanzee; go = gorilla). Tree
topologies are after [4], and after [10] for the Laverania.
Alongside Plasmodium falciparum [1], the other human alaria p rasites P. vivax [6,11],
P. malariae, P. oval curtisi and P. ovale wallikeri [12–14] have been s quenced. Other mem-
bers of the subgenus Laverania, parasites of African great apes, have been sequenced
including the chimpanzee par sites P. reichenowi and P. adleri and gorilla parasites P. gaboni,
P. blacklocki and P. billcollinsi [10,15]. A P. vivax-like parasite of great apes has also been
sequenced [13]. The simian parasite of macaques nd zoonotic human pathogen P. knowlesi
has been sequenced [16,17], as well as other simian parasites includi g P. coatneyi [18]
and P. cynomolgi [8,9]. Outside of the primate malarias, the genomes of rodent malaria
parasites P. berghei, P. chabaudi chabaudi and P. yoelii yoelii, important model species for
the study of malaria biology, have been sequenced [7,19–22]. Two avian malaria species,
P. gallinaceum and P. relictum, have been sequenced [23]. Additional strains have also
been independently sequenced and assembled for P. falciparum [24], P. vivax [6,11] and
P. cynomolgi [8,9]. Together, this represents an enviably richly sequenced genus.
Having so many species’ genomes provides a rich resource for studying evolution
in the genus. For example, an early study of comparative structural genomics between
P. falciparum and rodent malaria parasites showed extensive chromosome structural rear-
rangement and that lineage-specific genes could often be found at the breakpoints of these
translocations [25]. More recently, third-generation long read sequencing has provided
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further insights into the genomic architecture of Plasmodium. The central region of each
chromosome, around the centromere, comprises a relatively stable ‘core genome’ charac-
terised by broad co-linearity and one-to-one homology of the genes among genomes. An
estimated 90% [26] or more [24,26] of the genome has been suggested to be ‘core genome’.
The outer ‘subtelomeric regions’ are much more variable and are enriched for large and hy-
pervariable gene families such as the variant surface antigens var, rifin and stevor [25,27–30],
likely due to increased activity of processes like slipped-strand mispairing and ectopic
recombination generating new genes and segmental duplications. The repetitive nature of
the subtelomeric regions made them particularly difficult to study until long read sequenc-
ing technologies became more advanced [16,24]. The insight afforded by these advances is
important because of the key roles played by some of these gene families in the infection
biology of the parasite, such as immune evasion and sequestration of infected red blood
cells. Large multi-gene families show different distributions among Plasmodium species;
for example, the kir and SICAvar expanded gene families of P. knowlesi are not confined to
the subtelomeres but occur throughout the genome [16,17]. Links between the structural
genomics and the biology of different Plasmodium species will be an interesting area of
study made possible by the advances in sequencing technologies.
A densely sequenced genus has other advantages. Comparative genomics among
more closely related species allows the dating of gene family expansions [10,31] and the
identification of processes such as introgression and horizontal gene transfer [10,32,33], both
of which can play major roles in adaptation and virulence. Among members of the Lavera-
nia, one introgression event is of particular interest. It transferred orthologues of members
of a key erythrocyte invasion complex (rh5 and cyrpa) from an ancestor of the gorilla para-
site P. adleri to the lineage leading to P. falciparum and its sister species, the gorilla parasite
P. praefalciparum [10,32,33]. These genes, along with the proteins P113 and RIPR form a pro-
tein complex that is essential for red blood cell invasion [34–37]. RH5 binds the erythrocyte
surface protein Basigin and displays differential binding efficiency to human, gorilla and
chimpanzee Basigin, implicating it as a key determinant of host specificity [38–40] and a
vaccine candidate [41].
Identification of cryptic or incipient species is the point where inter-specific compar-
ative genomics meets population genomics, discussed in the next section. Two notable
examples here are the human parasite Plasmodium ovale and the simian parasite Plasmod-
ium knowlesi. Plasmodium ovale is now recognised to be two distinct, non-recombining
lineages, called Plasmodium ovale curtisi and Plasmodium ovale wallikeri [5]. Recognition of
this previously cryptic diversity is evolutionarily significant, but also relevant to the clinical
manifestations of infection. For example, Plasmodium ovale wallikeri displays a shorter la-
tency period (time to onset of symptoms, linked to the dormant liver hypnozoite life-cycle
stages) and deeper thrombocytopaenia (low blood platelet levels) than Plasmodium ovale
curtisi [42–45]. In addition, where malaria transmission is seasonal, as it is in much of
West Africa, latency periods are significantly lower during transmission season [42,43].
Plasmodium knowlesi, which naturally infects macaques but can be transmitted to humans,
is found across southeast Asia following the distribution of its macaque hosts. Population
genomics indicates both putative cryptic lineages and large-scale introgression, discussed
in the next section.
3. The Variable Genome: Genomic Diversity within Plasmodium Species
Population level re-sequencing of Plasmodium genomes has allowed population ge-
nomics to be studied in great detail, both to identify geographical population structure and
genome regions under various selection pressures including anti-malarial drugs and the
host’s adaptive immune response (Figure 2). For an excellent review of malaria population
genomics, see [46]. The large-scale data-sharing Malaria Genomic Epidemiology Net-
work (MalariaGEN) has made available thousands of parasite genomes—7000 P. falciparum
genomes from 28 countries at the time of writing—to the research community [47,48]. The
data provide an unprecedented snapshot of P. falciparum population genetics and the asso-
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ciated advances in sample preparation, sequencing technology, analysis methods and data
sharing lay the foundations to more fully integrate genomics into disease epidemiology,
though technical challenges remain [49,50].
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Figure 2. Plasmodium falciparum population genomics. (A) Map representing spread of the globally
distributed species P. falciparum from sub-Saharan Africa to South America and Asia and the differing
selection pressures that may drive local adaptation to different settings within and between continents:
climatic and environmental conditions (sun and cloud); different vector species (the mosquito);
differing treatment regimes (the pill). Below the map is a schematic population structure tree based
on genome-wide variation data, after [48]. (Regional populations are indicated at the tips of the tree:
SAm = South America; WA = West Africa; C C ntral Africa; EA = East fric ; S s South Asia;
SEA,W t East Asia, est; SEA,W = South East Asia, East; O = Oce nia). (B) Representation of
a genome-wide scan f r signatures of selection. Indices (e.g., homozygosity or linkage disequilibrium
within a population, FST among populations, etc.) are plotted on the y-axis across all chromosomes on
the x-axis (here, for P. falciparum’s 14 chromosomes) to identify outlier regions, such as the chloroquine
resistance transporter gene (crt) region on chromosome 7 shown here. Data points could be individual
variant sites, genes or other chromosomal regions, depending upon the index being plotted. By
highlighting outliers compared to a genomic average, confounding effects of population histories
can be avoided.
P. falciparum arose in Africa. Until recently, it was thought to have evolved from an
ancestor that infected the common ancestor of humans and chimpanzees, and to have
speciated with its hosts (into P. falciparum in humans and P. reichenowi in chimpanzees).
More recent sampling of the Laverania subgenus suggests a likely cross-species trans-
mission from gorillas, as its closest relative is the gorilla parasite P. praefalciparum [51,52].
Perhaps due to this recent host switch the historical P. falciparum populations underwent a
population bottleneck that is evident today in the low level of genetic diversity present in
the species, much lower than in the other Laverania [10,52,53], or in P. vivax [54].
Before genomic data were available for P. falciparum, microsatellite genotyping showed
a population structure reflecting current transmission intensities in different parts of the
world [55]. For example, extensive outcrossing occurs in many parts of sub-Saharan Africa
where transmission intensity is high, as the obligately sexual parasite more frequently
encounters gametes from other parasites in the mosquito host. This leads to extremely
low linkage disequilibrium (LD) even between genes in close proximity on a chromosome
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and to low divergence (as measured by FST) among populations. In other regions where
transmission rates are lower, mixed-genotype infections are rarer and selfing is more
the norm leading to LD over a greater range on chromosomes and to higher FST among
populations [55]. The increased resolution of whole-genome population resequencing
allowed the identification of fine population structure and the recognition of different
populations [56]. For example, across sub-Saharan Africa, genome-wide genetic diversity
defines East, West, Central and other ancestral parasite populations [48,56,57], including a
highly divergent population in the Horn of Africa [57].
Alongside whole genome resequencing, still relatively expensive despite falling costs,
the development of other ‘post-genomic’ tools such as SNP ‘barcoding’ panels [58–60]
has allowed parasite population structures to be studied. This approach has been used
in a number of studies of Plasmodium vivax [61–66]. P. vivax, like P. falciparum, may have
originated in Africa and be of gorilla origin [52], though some lines of evidence support a
simian origin in Asia [67]. Today Plasmodium vivax is the most geographically widespread
of the human malarias, and accounts for an increasing proportion of malaria cases in many
endemic areas [68]. The species is more genetically diverse than P. falciparum [54,69] which
may partly reflect low diversity and a more recent bottleneck in P. falciparum, but may also
partly reflect its distinctive population structure. In co-endemic regions, the population
structures of P. vivax have often been seen to differ from P. falciparum, being more genetically
diverse and less geographically structured [65,69–71]. The population genetics of P. vivax
varies across its range. In Latin America high levels of differentiation are seen among
sites, suggested to indicate multiple independent introductions of the parasite [72–75]. In
southeast Asia, genetic diversity tends to be high, with lower differentiation among differ-
ent regions and countries [72–76]. Little population structure and high genetic diversity
is seen in the south Pacific [69,77,78]. P. vivax is rare, though not absent, across much
of Africa [79] due to the prevalence of the Duffy antigen negative blood group in many
African populations; the Duffy antigen being the primary receptor required for erythrocyte
invasion [79,80]. African endemic foci are found in Madagascar and the Horn of Africa
in the east [79–81] and Mauritania in the west [61–63], with patterns of genetic diversity
and divergence from geographically distinct populations indicating long-lived, endemic
populations [61–63]. The contrast between P. vivax and P. falciparum in co-endemic regions
(e.g., [65,71]) is significant because the fracturing of parasite populations into smaller,
distinct, isolated subpopulations, fewer polyclonal infections, less outcrossing, increased
linkage disequilibrium and reduced genetic diversity are all indicators of falling endemicity
due to successful disease control. Therefore, the absence of these indicators in P. vivax in
some settings suggests a greater resilience of the species to malaria control interventions.
In some cases P. vivax appears to retain, somewhat paradoxically, high genetic diversity
even with high LD [82] or declining transmission [83], whether as a result of more recent
populations fracturing, epidemic transmission patterns, the effects of selection or the effects
of relapse from dormant hypnozoites is not fully determined.
The population structure of the simian parasite and human zoonosis Plasmodium
knowlesi has been best studied in Bornean and Peninsular Malaysia. The parasite shows
highly differentiated subgroups, broadly associated with their natural vertebrate host
species: long tailed (Macaca fascicularis) and pig tailed (Macaca nemestrina) macaques [84].
Both are found in human infections in Bornean Malaysia [85–88]. A third divergent
population is documented in both humans and macaques on Peninsular Malaysia [89–91].
Further substructure is seen within this Peninsular Malaysia population [90]. Moreover,
whole genome sequencing has shown evidence of introgression and a mosaic structure
of the P. knowlesi genome, indicating a breakdown of genetic isolation between divergent
groups [85–88]. This complex population structure should be studied further as it may
provide important insights into transmission and pathogenesis in this zoonotic parasite.
In addition to population structure, another area of major interest in Plasmodium
genome biology is the identification of genes evolving under selective pressures favouring
novel alleles or maintaining diversity within populations. The effects and, importantly, the
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targets of specific forces like anti-malarial drug exposure or protective adaptive immunity
can be identified. Prior to large-scale genomic re-sequencing, considerable efforts were
expended in disentangling the effects of selection and population processes (such as popu-
lation subdivision or population expansion) on population genetic indices, such as Tajima’s
D, based on population allele frequencies (for a review see [92]). Genome-scale data allows
population effects (that will tend to affect the whole genome) and selection effects (the
effects of which are more localised) to be separated more easily, as gene or genome region
indices can be compared to the distribution of the index across the genome in order to
identify outliers. Such whole genome scans for selective sweeps—genome regions with
reduced levels of genetic diversity or heterozygosity, or elevated LD—pinpoint chromoso-
mal regions associated with drug-resistance, clearly visible in continent-wide patterns of
P. falciparum genomic diversity [57]. These characteristic signatures mark loci associated
with resistance to different antimalarial drugs. The dhfr and dhps genes, encoding targets
of sulfadoxine and pyrimethamine (used in combination as sulfadoxine-pyrimethamine;
SP) show clear signatures of recent strong selection in both P. falciparum [93,94] and P. vi-
vax [95–97], even where SP is not a first line treatment of vivax malaria, possibly showing
an ‘off-target’ effect of falciparum malaria treatment. The chloroquine resistance gene crt
shows similar signatures of selection on resistance alleles in P. falciparum [93], while gene
amplification has been reported at the crt and multidrug resistance gene mdr1 loci [96,98,99].
In addition to this, recent selection on the region upstream of crt has also been reported in
Ethiopian P. vivax [100].
In the case of resistance to the artemisinin, antimalarials the picture is complex. The
first descriptions of slower P. falciparum parasite clearance in response to artemisinin were
from Cambodia, and subsequently the phenotype spread across southeast Asia [101–103].
Numerous studies have associated resistance with mutations in the kelch13 gene on P. falci-
parum chromosome 13 [101,104–107], though a large number of different kelch13 mutations
exist [108] and cases of slow parasite clearance have been described in Africa in the absence
of known kelch13 resistance makers [109]. The precise role of kelch13 in resistance is unclear
and is the subject of intense research. Indeed, the mechanism of resistance to artemisinins
may differ from that to other drugs in being broader and involving changes to many cellular
processes affecting the cell cycle and cellular housekeeping and stress-response processes
including the unfolded protein response [110–113]. Such a broad response can complicate
the search for reliable genetic markers of resistance, markers that are vitally important
for monitoring the spread of the phenotype from southeast Asia to sub-Saharan Africa.
Alongside kelch13 variants, large scale genomic re-sequencing of southeast Asian parasite
populations associated the resistance phenotype with variants in several other genes (fd,
mdr2, crt, arps10) [105]. Another large-scale re-sequencing study showed 155 SNPs within
kelch13 of which 128 were found in African and 62 in southeast Asian parasites [47]. Analy-
sis of their genetic backgrounds, a key benefit of the whole genome sequencing approach,
indicated that the African variants arose independently within Africa, rather than being
transferred from southeast Asia, yet they do not appear to be associated with artemisinin
resistance in Africa [47]. It has been suggested that certain genetic backgrounds, common
in southeast Asia but not Africa, may predispose for kelch13 resistance mutations and
explain the association seen with variants in several other genes [105].
Genome-scale scans of indices of divergence among populations can pinpoint genes
under differential selection among these populations. For example, P. falciparum popula-
tions from countries with differing transmission patterns show unusually high divergence
(as measured by the fixation index FST) coinciding with a gene (gdv1) associated with
sexual differentiation [114,115]. In addition to this, apparent differential selection in crt
was seen between two west African countries: Gambia and Guinea [114,115]. Selection
driven by other pressures can also be detected in the genomes of parasites. For example,
the globalisation of P. falciparum required adaptation to different vector species. Consistent
with this, genes expressed in the mosquito stages of the parasite’s life cycle are among the
Genes 2021, 12, 843 7 of 18
most geographically divergent in the genome [48] and signatures of adaptation are visible
in a number of these genes [116].
4. The Dynamic Genome: Methylomics in Plasmodium
Genomics has allowed us to understand Plasmodium population level processes in
unprecedented detail. However, other ‘omes’ also offer useful windows into aspects of
the parasite’s biology that cannot always be studied using genetic variation alone. Under-
standing how malaria parasites regulate their gene expression is crucial to comprehend
Plasmodium biology, from the radical changes between life-cycle stages to the expression of
alternative invasion pathway proteins and other host-parasite interaction proteins. One
way to study this is by transcriptomic quantification of expressed RNA [117–122]; another
is by epigenomics: mapping of epigenetic marks in the DNA or chromatin structure of the
genome [123–128]. DNA methylation in Plasmodium represents a potential new frontier in
Plasmodium genomics, yet it remains far from being fully understood and its existence has
been somewhat controversial. Here, we consider DNA methylation in P. falciparum.
During erythrocyte infection the P. falciparum genome is mostly euchromatic [129,130].
Nevertheless, epigenetic mechanisms to control gene expression involving non-coding
RNAs, the use of alternative histone variants and histone post-translational modifications
are well documented [123–125]. Whether the Plasmodium epigenetic machinery also in-
cluded DNA methylation, and in particular 5-methylcytosine (5mC), was a question that
awaited an answer for a long time. The apparent lack of 5mC added to other characteris-
tics of Plasmodium: lack of a functional RNA interference system [131] and linker histone
H1 [131,132] and a mainly euchromatic genome [129,130]. Moreover, Plasmodium would not
be the only eukaryote dispensing with 5mC: the fruit fly Drosophila melanogaster presents
an extremely low level (less than 0.01%) of 5mC [133] and Caenorhabditis elegans, Trichoplax
adhaerens, Schmidtea mediterranea, the urochordate Oikopleura dioica, the rotifer Adineta vaga
have all dispensed with 5mC [134,135].
However, in eukaryotes 5mC plays a major role in many different processes including
genomic imprinting, DNA repair, response to stress and the environment, regulation of
gene expression and immune response [133,136–139]. The AT-rich Plasmodium genome [1]
represents an obstacle for mass spectrometry-based methods to detect 5mC [140,141] and
early analyses did not detect it [140]. Even though approaches that utilize methylation
sensitive restriction enzymes (cutting at CG rich sites) and immunoprecipitation are not
ideal to properly interrogate the AT-rich Plasmodium genome, a methylation-sensitive
restriction approach identified a signature of 5mC in the Dihydrofolate Reductase Thymidylate
Synthase (DHFR-TS) gene [142].
Recent advances in the sensitivity of mass spectrometry and the sequencing of bisulfite
treated DNA have allowed better investigation of 5mC in Plasmodium [126–128]. Bisul-
fite treatment converts unmethylated cytosines into uracils and permits differentiation
between methylated and unmethylated sites [143]. It is possible, therefore, sequencing
the bisulfite converted DNA, to discern between methylated-cytosines (read as C) and
unmethylated-cytosine (read as T). Comparing the sequence of the bisulfite treated genome
with a reference genome it is possible to identify methylated and unmethylated cytosines
and the proportion of cytosines in the genome that are methylated. In addition, at every
cytosine site the proportions of reads containing methylated and unmethylated cytosine
can be seen, indicating the proportion of cells in a sample that are methylated at a given
position. Using liquid chromatography-tandem mass spectrometry (LC-MS/MS), Ponts
and collaborators were able to clearly identify signatures of 5mC in the P. falciparum genome
and suggested between 0.36% and 1.31% of all cytosines were methylated, depending on
the stage analysed (ring, trophozoite or schizont) [128]. This was corroborated by deep se-
quencing of bisulfite treated P. falciparum DNA recovered from an asynchronous population
that returned 0.58% methylated cytosines [128]. McInroy and colleagues found a remark-
ably similar pattern of DNA methylation in the rodent parasite Plasmodium berghei [127].
They used LC-MS/MS and a PCR-free bisulfite sequencing method (‘recovery after bisul-
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fite treatment’; ReBuilT) to investigate the P. berghei genome for signatures of 5mC. Mass
spectrometry and ReBuilT indicated, respectively, 0.33% and 1.87% of all cytosines were
methylated.
Recent findings suggest that the majority of modified cytosines in P. falciparum may
not in fact be 5mC, but 5-hydroxymethylcytosine (5hmC) [126]. This modified cytosine is
derived from the Ten-Eleven Translocation methylcytosine dioxygenase (TET) mediated
oxidation of the methyl group (-CH3 -> CH2OH) of 5mC [144] (Figure 3). TET is part of
the pathway to restore unmethylated cytosine: TET catalyzes the conversion of 5mC to 5-
carboxylcytosine (5caC), via the intermediates 5hmC and 5-formylcytosine (5fC) [145–148];
then, uracil-DNA glycosylase and base-excision repair (BER) excises and repairs 5caC
back to unmethylated cytosine [145–147,149] (Figure 3A). Hammam and colleagues used a
variety of methods to query methylation levels in P. falciparum, including ELISA, bisulfite
sequencing (BS-seq) and oxidative bisulfite sequencing (oxBS-seq), hydroxymethylated
DNA immunoprecipitation (hmeDIP) and LC-MS mass spectrometry [126]. Using anti-
5mC or anti-5hmC antibodies in different Plasmodium life cycle stages (Ring, Trophozoite,
Schizont) and ELISA, they estimated 0.19–0.38% cytosine to be 5hmC and only 0.01–0.02%
to be 5mC [126]. These proportions were corroborated using a combination of BS-seq and
oxBS-seq (0.2–0.26% 5hmC-like and 0.01–0.02% 5mC) [126]. The bisulfite reaction that is
part of the BS-seq protocol is unable to convert 5mC or 5hmC into uracil, therefore BS-seq
cannot distinguish between these 2 cytosine modifications [150,151]. However, in oxBS-seq
5hmC is first oxidised to 5fC that bisulfite treatment can convert to uracil allowing, by com-
paring BS-seq and oxBS-seq results, the level of 5hmC to be quantified [150,151] (Figure 3B).
Hydroxymethylated DNA immunoprecipitation (hmeDIP) followed by next generation se-
quencing [152,153] showed the vast majority (98–98.5%) of 5hmC occurred in genic regions
while only around 1–1.5% was intergenic, and that most was found in a CHH context (H
representing any nucleotide but G) [126]. Further, hydroxymethylated genes had high lev-
els of mRNA expression in all life-cycle stages analysed in the study [126]. Oddly, LC-MS
did not identify 5hmC but gave a similar signal that could belong to a more hydrophobic
positional isomer (5hmC-like modification) [126]. Overall, Hammam et al.’s [126] results
corroborated previous findings on the level and distribution of DNA methylation in Plas-
modium [127,128], but suggest also that the predominant cytosine modification is 5hmC
(or 5hmC-like).
The mechanistic role of 5mC in Plasmodium is not clear (Figure 3C). In mammals, most
5mC are found in CG duplexes; however, that is not the case in P. falciparum where the
vast majority of 5mC are found in CHH contexts [128]. This is also seen in P. berghei (CAH
is particularly common), where only a small proportion was associated with CG, CC or
CHG [127]. The distribution of methylation in P. falciparum, with more methylation in
the gene body than in intergenic regions and demarcating exon-intron boundaries, is also
seen in other lineages [135] and may suggest a role in regulating alternative splicing [154]
or RNA polymerase II DNA binding affinity [155]. In P. berghei, methylation seems to be
equally distributed between genic and intergenic regions though within genes methylation
seems to be mostly exonic and to mark intron–exon boundaries [127].
There seems to be a correlation between the distribution of 5mC and specific his-
tone modifications in P. falciparum. Heterochromatin is characterized by H3K9me3 while
transcriptionally active euchromatin is marked by H3K9ac and H4K20me3, at least in var
genes [123–125]. H3K9ac and H3K4me3 associate to the coding region of actively expressed
genes while H3K36me2 is a marker of repression. Cytosine methylation levels increase
downstream of histone markers (H3K9ac and H3K4me3) linked to higher expression,
while methylation levels do not change around silencing histone markers (H3K9me3 and
H4K20me3) [128]. It is important to note here, that in many metazoans, H3K4me3 anti-
correlates with 5mC due to the reduced affinity of DNMT3 ADD domain for this histone
modification [156,157].
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(5fC) and 5fC to 5-carboxylcytosine (5caC). Uracil-DNA glycosylase (TDG) and base-excision re-
pair (BER) converts 5caC back to (unmethylated) cytosine. (B) The standard genomic method to 
detect 5mC (bisulfite treatment to convert unmethylated C to uracil, seen as a T in the final se-
quencing library, followed by whole genome sequencing) cannot distinguish 5mC from 5hmC. 
The addition of an oxidation step, converting 5hmC to 5fC (which bisulfite treatment does convert 
to uracil) can allow 5hmC to be detected and quantified. This approach suggests the majority of 
methylated C in Plasmodium is 5hmC. (C) Epigenetic marks (black lines with red circles) are shown 
on a stretch of DNA (grey = intergenic/intronic; black = exonic). In Plasmodium, exonic sequence 
near to intron-exon boundaries is enriched for these modified cytosines. Possible functional conse-
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Figure 3. Epigenomics in Plasmodium. (A) Cytosine can be converted to 5-Methylcytosine (5mC)
by DNA methyltransferase (DNMT), and 5mC to 5-Hydroxymethylcytosine (5hmC) by Ten-eleven
translocation methylcytosine dioxygenase (TET), which also converts 5hmC to 5-formylcytosine
(5f ) and 5f to 5-carboxylcytosine (5ca ). racil- glycosylase (T ) and base-excision repair
(BER) converts 5caC back to (unmethylated) cytosine. (B) The stand r genomic method to detect
5mC (bisulfite treatment to convert unmethyla ed C to uracil, seen as a T in the final sequ ncing
library, followed by whole genome sequencing) cannot distinguish 5mC from 5hmC. The addition
of an oxidation step, converting 5hmC to 5fC (which bisulfite treatment does convert to uracil) can
allow 5hmC to be detected and quantified. This approach suggests the majority of methylated C in
Plasmodium is 5hmC. (C) Epigenetic marks (black lines with red circles) are shown on a stretch of
DNA (grey = intergenic/intronic; black = exonic). In Plasmodium, exonic sequence near to intron-exon
boundaries is enriched for these modified cytosines. Possible functional consequences include gene
silencing or upregulation, and alternative splicing. Genome-wide patterns of methylation could act
as alternative markers for gene expression.
The fact that methylation profiles are different between DNA strands and that methy-
lation levels change among life cycle stages suggest most if not all 5mC in Plasmodium is de
novo methylation [128]. This implies that Plasmodium must express enzymes to add and
remove 5mC. The eukaryotic methylation toolkit includes six DNA Methyltransferases
(DNMTs) with different domains and different phylogenetic relationships, three Ten-Eleven
Genes 2021, 12, 843 10 of 18
Translocation methylcytosine dioxygenase (TET) and eleven Methyl-CpG Binding Domain
(MBD) readers [135,145,147]. Some eukaryotic lineages have duplicated or lost some of
the main DNMTs and other components of the methylation toolkit [135]. Initial investi-
gations identified only one DNMT2 in the Plasmodium genome [128]. In mammals and
other eukaryotes, different DNMTs have dedicated roles. DNMT1 seems to be the ded-
icated ‘maintenance methyltransferase’, replicating the methylation signature to newly
formed DNA strands after cell division [135,145,147]. DNMT3 is the dedicated ‘de novo
methyltransferase’, adding new methyl markers, often asymmetrically, to DNA strands.
DNMT2 is evolutionarily highly conserved, but its role seems to be associated to tRNA
methylation and species that only express this methylases often lack 5mC [145,158]. Indeed,
Plasmodium aspartic tRNA is methylated by Plasmodium DNMT2 (TRDMT1) [159]. Impor-
tantly, Hammam and colleagues, using ELISA, demonstrated TET hydroxylase activity
in Plasmodium nuclear extracts however they could not identify a TET homologous in the
P. falciparum genome [126].
Plasmodium methylation context (mostly CHH) may suggest possible components of
its methylation system. Similarities and differences between eukaryotic lineages suggest
a great diversity and plasticity in the evolution of mechanisms of 5mC and its func-
tion [135]. For example, animals have well conserved DNMT1 and DNMT3 genes but
display substantial differences in the distribution and level of 5mC, ranging from hyperme-
thylated to sparsely methylated genomes in mammals and hymenoptera respectively [135].
DNMT5 mediates nucleosomal linkers methylation in some marine algae, but this pattern
is not replicated in DNMT5-expressing fungi [160,161] and in some plants DNMT3 only
methylates CHH context [162]. This suggests that the particular pattern of methylation ob-
served in an organism may be the results of the activity of modulators (e.g., MDB proteins)
that control DNMT activity. It is also possible that methylated cytosines in CHH context
serve as binding sites for MDB proteins [147]. In mammal brains MeCP2 (an MDB protein
family member) binds 5mC in non-CpG context and regulates gene expression [163–166].
The recent discovery that the more abundant cytosine modification in P. falciparum
is indeed 5hmC may have implications for how this epigenetic marker modulates gene
expression. The 5hmC signature is read by specific members of the MBD protein family
such as methyl-CpG binding protein2 (Mecp2), methyl-CpG binding domain proteins 4
(Mbd4), Kaiso and SRA (reviewed in [167]). Mbd4 was also implicated in the process of
demethylation converting 5hmC in 5hmUracil by deamination [168]. The 5hmC was also
found to be particularly enriched in embryonic stem cells and brain tissues in euchromatic
regions and in gene bodies, where its level correlated with gene expression [153,168–172].
It is becoming apparent that Plasmodium epigenetic machinery does include DNA
methylation but much remains unknown. Bioinformatic approaches have at times been
insufficient to identify Plasmodium orthologs [1] and these approaches failed to clearly
identify the components of Plasmodium methylation/demethylation pathway. It is possible
that MDB proteins play fundamental roles in modulating DNA methylation/demethylation
in Plasmodium and that may even be the crucial component of this pathway. The role of
5hmC, as well as 5fC, needs further consideration. 5fC was found at promoters of active
genes and in association with H3K4me3 in ES cells, again underlining the connection
between cytosine modifications, histone modifications and gene expression [173–175].
Methodological advances are helping to overcome some of the limitations imposed by
Plasmodium’s AT-rich genome on fully investigating the role of cytosine modification. For
example, the PCR-free ‘ReBuilT’ approach used by McInroy et al. [127] recovers many
sequence fragments that are usually lost during bisulfite sequencing library preparation
and avoids PCR amplification biases (favouring GC-rich DNA).
5. Conclusions
Recent years have seen huge advances in Plasmodium genomics. Through intensive
and extensive study of the genomes of these parasites, we have learned a great deal about
their origins, evolution and biology. Future prospects include the further embedding of
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genomics in malaria epidemiology as well as advances in, and possible large-scale analysis
of, the other ‘omics of malaria to gain further insights into this deadly, fascinating parasite.
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